| MIIG 115 Minimally-Invasive Injectable
Graft
Anatomic Pore Structure. Cellular
Affinity* Bone Repair Scaffold
Injects. Hardens.
Replaced By Bone.
MIIG® Injectable Graft has been developed
for less invasive fracture treatment in contained metaphyseal
defects with open or closed reduction. The injectable graft
hardens inside the body, provides temporary intraoperative
stabilization, and is receptive to adjunctive hardware.
OSTEOSET® Surgical-Grade Calcium Sulfate
has demonstrated clinical efficacy as an osteoconductive biomaterial.
Wright Medical's proprietary alpha crystal technology reliably
produces a bone graft that performs particularly well in contained,
metaphyseal defects such as those in the tibial plateau, distal
radius or in pilon fracture.
MIIG® 115 Graft Design Features
- Injects through small gauge needle
- Hardens in defect
- May be drilled to accommodate hardware placement
- Provides temporary intraoperative fracture stabilization
- Completely resorbs
- Regenerates bone
- Ideal for metaphyseal defects
For more information
on the MIIG 115 Minimally-Invasive Injectable Graft such as
brochures, articles, video etc., please contact
Ortotech directly or visit the official homepage
http://www.wmt.com/Physicians/Products/Biologics/
MIIGMinimallyInvasiveInjectableGraft.asp
  
*Minimally Invasive Injectable
Graft is not a substitute for rigid internal or external fixation.
|
